A Randomized, Multicenter, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of a Quadruple Combination of Amlodipine, Losartan, Rosuvastatin, and Ezetimibe in Patients with Concomitant Essential Hypertension and Dyslipidemia

BACKGROUND: Few data are available regarding the efficacy and safety of a single-pill combination (SPC) consisting of four medications in patients with concomitant hypertension and dyslipidemia. OBJECTIVE: We aimed to determine the efficacy and tolerability of a fixed-dose SPC consisting of 5 mg aml...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Min Chul, Ahn, Youngkeun, Kim, Moo Hyun, Kim, Seok-Yeon, Hong, Taek Jong, Rhee, Moo-Yong, Kim, Sang-Hyun, Hong, Soon-Jun, Kim, Hyungseop, Kim, Weon, Chae, In Ho, Kang, Duk-hyun, Kim, Byeong-Keuk, Kim, Hyo-Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10328852/
https://www.ncbi.nlm.nih.gov/pubmed/37395974
http://dx.doi.org/10.1007/s40256-023-00590-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10328852/
https://www.ncbi.nlm.nih.gov/pubmed/37395974
http://dx.doi.org/10.1007/s40256-023-00590-9

Ejemplares similares